SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Flagrante Delictu who wrote (264)2/13/1998 2:47:00 PM
From: squetch  Read Replies (1) of 717
 
Bernie, Thanks for the info. I realize this is older, but I don't remember seeing it here. squetch

Proceedings of the National Academy of Sciences
Volume 93, Number 13; Pages: 6610-6615
Medical Sciences

Gadolinium(III) texaphyrin: A tumor selective radiation sensitizer that is detectable by MRI

Stuart W. Young, Fan Qing, Anthony Harriman, Jonathan L. Sessler, William C. Dow, Tarak D. Mody, Gregory W. Hemmi,
Yunpeng Hao, Richard A. Miller

c 1996 by the National Academy of Sciences

ABSTRACT Gadolinium(III) texaphyrin (Gd-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance imaging (MRI). This porphyrin-like complex has a high electron affinity [E 12 (red.) ~ 0.08 V versus normal hydrogen electrode] and forms a long-lived pi-radical cation upon exposure to hydrated electrons, reducing ketyl radicals, or superoxide ions. Consistent with these chemical findings, Gd-tex2+ was found to be an efficient radiation sensitizer in studies carried out with HT29 cells in in vitro as well as in in vivo single and multifraction irradiation studies with a murine mammary carcinoma model. Selective localization of Gd-tex2+ in tumors was confirmed by MRI scanning.

at-home.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext